Analysis of the kinetics of folding of proteins and peptides using circular dichroism.

PubWeight™: 1.24‹?› | Rank: Top 10%

🔗 View Article (PMC 2752309)

Published in Nat Protoc on January 01, 2006

Authors

Norma J Greenfield1

Author Affiliations

1: Department of Neuroscience and Cell Biology, Robert Wood Johnson Medical School, Piscataway, New Jersey 08854-5635, USA. greenfie@rwja.umdnj.edu

Articles citing this

Using circular dichroism spectra to estimate protein secondary structure. Nat Protoc (2006) 5.81

Using circular dichroism collected as a function of temperature to determine the thermodynamics of protein unfolding and binding interactions. Nat Protoc (2006) 3.48

Retracted Genetically engineered synthetic miniaturized versions of Plasmodium falciparum UvrD helicase are catalytically active. PLoS One (2014) 1.40

Membrane requirement for folding of the herpes simplex virus 1 gB cytodomain suggests a unique mechanism of fusion regulation. J Virol (2012) 1.05

Cytokeratins mediate epithelial innate defense through their antimicrobial properties. J Clin Invest (2012) 1.02

Energy landscapes and functions of supramolecular systems. Nat Mater (2016) 0.93

Engineered single-domain antibodies with high protease resistance and thermal stability. PLoS One (2011) 0.92

An overview of technologies for immobilization of enzymes and surface analysis techniques for immobilized enzymes. Biotechnol Biotechnol Equip (2015) 0.89

A molecular interpretation of 2D IR protein folding experiments with Markov state models. Biophys J (2014) 0.87

The mechanism by which a propeptide-encoded pH sensor regulates spatiotemporal activation of furin. J Biol Chem (2013) 0.86

Collagen-like proteins in pathogenic E. coli strains. PLoS One (2012) 0.85

Combinatorial active-site variants confer sustained clavulanate resistance in BlaC β-lactamase from Mycobacterium tuberculosis. Protein Sci (2014) 0.84

Unraveling the role of the C-terminal helix turn helix of the coat-binding domain of bacteriophage P22 scaffolding protein. J Biol Chem (2012) 0.84

Improving a natural CaMKII inhibitor by random and rational design. PLoS One (2011) 0.83

Protein helical structure determination using CD spectroscopy for solutions with strong background absorbance from 190 to 230nm. Biochim Biophys Acta (2014) 0.83

Structure-Activity Studies on Antiproliferative Factor (APF) Glycooctapeptide Derivatives. ACS Med Chem Lett (2010) 0.81

Order through disorder: hyper-mobile C-terminal residues stabilize the folded state of a helical peptide. a molecular dynamics study. PLoS One (2010) 0.78

Protein folding on biosensor tips: folding of maltodextrin glucosidase monitored by its interactions with GroEL. FEBS J (2016) 0.76

Protein evolution analysis of S-hydroxynitrile lyase by complete sequence design utilizing the INTMSAlign software. Sci Rep (2015) 0.75

Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors 1 and 2. Front Pharmacol (2015) 0.75

The cardiomyopathy-associated K15N mutation in tropomyosin alters actin filament pointed end dynamics. Arch Biochem Biophys (2017) 0.75

Articles cited by this

Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem (2006) 22.87

Computed circular dichroism spectra for the evaluation of protein conformation. Biochemistry (1969) 10.58

Protein misfolding, evolution and disease. Trends Biochem Sci (1999) 7.73

Folding of chymotrypsin inhibitor 2. 1. Evidence for a two-state transition. Biochemistry (1991) 6.55

Using circular dichroism spectra to estimate protein secondary structure. Nat Protoc (2006) 5.81

Experimental and theoretical aspects of protein folding. Adv Protein Chem (1975) 3.51

Using circular dichroism collected as a function of temperature to determine the thermodynamics of protein unfolding and binding interactions. Nat Protoc (2006) 3.48

Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry (1992) 3.19

Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity. J Mol Biol (2001) 2.80

Hydrogen exchange methods to study protein folding. Methods (2004) 2.47

The nature of protein folding pathways: the classical versus the new view. J Biomol NMR (1995) 2.11

Poly(pro)II helices in globular proteins: identification and circular dichroic analysis. Biochemistry (1994) 2.06

Is polyproline II a major backbone conformation in unfolded proteins? Adv Protein Chem (2002) 1.99

Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro. J Mol Biol (1999) 1.89

An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured. Biochemistry (2001) 1.85

Probing the folding mechanism of a leucine zipper peptide by stopped-flow circular dichroism spectroscopy. Biochemistry (1995) 1.78

Protein misfolding, amyloid formation, and neurodegeneration: a critical role for molecular chaperones? Neuron (2002) 1.78

The aggregation kinetics of Alzheimer's beta-amyloid peptide is controlled by stochastic nucleation. Protein Sci (2005) 1.74

Equilibrium thermal transitions of collagen model peptides. Protein Sci (2004) 1.65

Physical evidence for the assembly of A and B chains of human placental collagen in a single triple helix. Eur J Biochem (1978) 1.61

Substrate stabilization of lysozyme to thermal and guanidine hydrochloride denaturation. J Biol Chem (1980) 1.45

Effect of temperature on the circular dichroism spectra of polypeptides in the extended state. Biopolymers (1972) 1.42

Intermediates in protein folding reactions and the mechanism of protein folding. Annu Rev Biochem (1975) 1.39

Folding of peptide models of collagen and misfolding in disease. Curr Opin Struct Biol (1999) 1.34

Determination of the folding of proteins as a function of denaturants, osmolytes or ligands using circular dichroism. Nat Protoc (2006) 1.32

Protein-folding kinetics and mechanisms studied by pulse-labeling and mass spectrometry. Mass Spectrom Rev (2003) 1.24

Guanidine hydrochloride-induced denaturation and refolding of transthyretin exhibits a marked hysteresis: equilibria with high kinetic barriers. Biochemistry (1997) 1.24

A kinetic study of beta-lactoglobulin amyloid fibril formation promoted by urea. Protein Sci (2002) 1.22

Nucleation and propagation of the collagen triple helix in single-chain and trimerized peptides: transition from third to first order kinetics. J Mol Biol (2002) 1.21

The triple helix in equilibrium with coil conversion of collagen-like polytripeptides in aqueous and nonaqueous solvents. Comparison of the thermodynamic parameters and the binding of water to (L-Pro-L-Pro-Gly)n and (L-Pro-L-Hyp-Gly)n. Biopolymers (1977) 1.21

Characterization of collagen-like peptides containing interruptions in the repeating Gly-X-Y sequence. Biochemistry (1993) 1.13

Characterization of the product formed by renaturation of alpha 1-CB2, a small peptide from collagen. Biochemistry (1970) 1.10

Methods for exploring early events in protein folding. Curr Opin Struct Biol (1999) 1.07

Contribution of advanced glycosylation to the amyloidogenicity of islet amyloid polypeptide. Eur J Biochem (1998) 1.06

Pathways and mechanisms of protein folding. Adv Biophys (1984) 1.06

Protein misfolding and disease: the case of prion disorders. Cell Mol Life Sci (2003) 1.03

Rapid mixing methods for exploring the kinetics of protein folding. Methods (2004) 1.00

Kinetic studies of protein folding using NMR spectroscopy. Nat Struct Biol (1998) 0.99

Insights into protein folding from NMR. Annu Rev Phys Chem (1996) 0.99

Fluorescence methods for studying kinetics of protein-folding reactions. Methods Enzymol (1997) 0.96

Fluorescence spectroscopy. Methods Mol Biol (1995) 0.94

Type I collagen CNBr peptides: species and behavior in solution. Biochemistry (1996) 0.93

Huntington's disease: new frontiers for molecular and cell therapy. Curr Drug Targets (2005) 0.91

Folding of the multidomain ribosomal protein L9: the two domains fold independently with remarkably different rates. Biochemistry (1999) 0.89

Equilibrium and kinetic studies of the helix-coil transition in alpha 1-CB2, a small peptide from collagen. Biochemistry (1970) 0.87

Structural control of self-assembled nanofibers by artificial beta-sheet peptides composed of D- or L-isomer. J Am Chem Soc (2005) 0.84

Cytotoxicity of prion protein peptide (PrP106-126) differs in mechanism from the cytotoxic activity of the Alzheimer's disease amyloid peptide, A beta 25-35. Neurodegeneration (1996) 0.84

Experimental studies of folding kinetics and structural dynamics of small proteins. Adv Biophys (1984) 0.84

Nuclear magnetic resonance and circular dichroism studies of a triple-helical peptide with a glycine substitution. J Mol Biol (1992) 0.82

Structure and influence on stability and activity of the N-terminal propeptide part of lung surfactant protein C. FEBS J (2006) 0.81

Circular dichroism. Methods Mol Biol (1995) 0.80

Protein folding mechanisms studied by time-resolved electrospray mass spectrometry. Biotechniques (2006) 0.79

Stability of type I collagen CNBr peptide trimers. J Mol Biol (1997) 0.79

All or none fibrillogenesis of a prion peptide. Eur J Biochem (2001) 0.79

pH jump studies of the folding of the multidomain ribosomal protein L9: the structural organization of the N-terminal domain does not affect the anomalously slow folding of the C-terminal domain. Biochemistry (2000) 0.77